Abstract
Simple SummaryPancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genetically modified KPC mouse model. In the absence of NEMO, KPC mice exhibited extended survival, which was accompanied by a strong reduction in the development of liver metastasis and ascites. Our study provides evidence for a detrimental role of the conventional NF-κB pathway in the survival of KPC mice and underlines the fact that NF-κB could be a therapeutic target against PDAC.Pancreatic ductal adenocarcinoma (PDAC) remains a largely incurable cancer type. Its high mortality is attributed to the lack of efficient biomarkers for early detection combined with its high metastatic properties. The aim of our study was to investigate the role of NF-κB signaling in the development and metastasis of PDAC. We used the well-established KPC mouse model, and, through genetic manipulation, we deleted NF-κB essential modulator (NEMO) in the pancreata of KPC mice. Interestingly, NEMO deletion altered the differentiation status of the primary tumor but did not significantly affect its development. However, in the absence of NEMO, the median survival of the mice was prolonged by 13.5 days (16%). In addition, examination of the liver demonstrated that, whereas KPC mice occasionally developed liver macro-metastasis, NEMO deletion completely abrogated this outcome. Further analysis of the tumor revealed that the expression of epithelial–mesenchymal transition (EMT) transcription factors was diminished in the absence of NEMO. Conclusively, our study provides evidence that NF-κB is dispensable for the progression of high-grade PanINs towards PDAC. In contrast, NF-κB signaling is essential for the development of metastasis by regulating the gene expression program of EMT.
Highlights
Pancreatic ductal adenocarcinoma (PDAC) represents the most common form of pancreatic cancer and remains one of the deadliest cancer types, with an overall 5-year survival rate of approximately 9%
nuclear factor κB (NF-κB) essential modulator (NEMO) Is Dispensable for the Development of PDAC but Modulates Progression of Tumors in NF-κB signaling is regulating the development of different types of cancer [18]
We investigated whether differences in the activity of NF-κB signaling affect the survival of PDAC patients
Summary
Pancreatic ductal adenocarcinoma (PDAC) represents the most common form of pancreatic cancer and remains one of the deadliest cancer types, with an overall 5-year survival rate of approximately 9%. It is expected to be the second leading cause of cancer-related deaths in the USA by 2030 [1,2]. Current strategies against pancreatic cancer involve treatment with chemotherapeutic agents such as gemcitabine and FOLFIRINOX [5]. This approach increases the survival of the patients only by a few months since in most cases, at the time of diagnosis, the tumor has already spread and metastasized [5].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
